Zotefoams supplies T-Tubes to Pfizer

For use at its expanded Grange Castle facility in Dublin, Ireland

Zotefoams installs a T-Tubes high performance cleanroom insulation system at the Grange Castle facility in Dublin

Zotefoams, a leading manufacturer of closed-cell cross-linked polyolefin foams, has been awarded a contract to supply its T-Tubes high performance cleanroom insulation system for Pfizer at its Grange Castle facility in Dublin. Initial deliveries of T-Tubes were supplied in July, in conjunction with ESI Technologies, Zotefoams' exclusive distributor in Ireland.

The pure and chemically resistant T-Tubes will be used in purification, cell culture and harvest and recovery suites, for heat and energy conservation, personal protection and the elimination of condensation and risk of bacteria growth. The simple construction and accelerated and reduced installation time will assist in the completion and commissioning of the expanded Grange Castle site, which will be used in the manufacture of an active pharmaceutical ingredient (API) for Pfizer's biologic drug programme.

T-Tubes’ proven track record in significantly reducing installation time and costs, reducing maintenance and operating costs, and eliminating the risk of bacteria growth due to its unique KYNAR PVDF closed cell structure, was a major factor in Pfizer’s decision to use it throughout the expanded cleanroom facilities at its US$2.25bn plant, says Zotefoams.

The Grange Castle development is one of the largest integrated biopharmaceutical plants in the world and is the only facility in Europe to manufacture biopharmaceuticals, pharmaceuticals and vaccines within the same facility.

Companies